Nkarta Inc (NKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NKTX | IPHA | SABS | ||
| Company | Nkarta Inc | Innate Pharma S.A. ADR | Sab Biotherapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.82 | 2.16 | 3.84 | ||
| High | 2.86 | 2.16 | 3.88 | ||
| Low | 2.64 | 1.93 | 3.59 | ||
| Latest | 2.64 | 2.02 | 3.70 | ||
| Change | -0.17 | -0.15 | -0.19 | ||
| % Change | -6.05% | -6.91% | -4.88% | ||
| Volume | 730,200 | 210,300 | 944,500 | ||
| 20-Day Average Volume | 994,470 | 147,460 | 1,066,355 | ||
| Previous Close | 2.81 | 2.17 | 3.89 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.03 | 1.49 | 3.75 | ||
| 20-Day Raw Stochastic | 5.16% | 53.85% | 24.53% | ||
| 20-Day Relative Strength | 47.14 | 64.11 | 47.98 | ||
| Weighted Alpha | +0.10 | -16.25 | +49.10 | ||
| Today's Opinion | 88% Buy | 8% Buy | 8% Sell | ||
| Previous Opinion | 88% Buy | 8% Buy | 40% Buy | ||
| Last Month's Opinion | 88% Buy | 56% Sell | 32% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -17.24% since 05/08/26 | +43.26% since 05/08/26 | -9.98% since 05/08/26 | ||
| Low | 2.64 on 05/15/26 | 1.32 on 05/13/26 | 3.54 on 05/12/26 | ||
| High | 3.32 on 05/11/26 | 2.62 on 05/14/26 | 4.27 on 05/11/26 | ||
| 1-Month | |||||
| %Chg | +9.09% since 04/15/26 | +19.53% since 04/15/26 | -8.64% since 04/15/26 | ||
| Low | 2.45 on 04/16/26 | 1.32 on 05/13/26 | 3.41 on 04/29/26 | ||
| High | 3.65 on 04/21/26 | 2.62 on 05/14/26 | 4.59 on 05/08/26 | ||
| 3-Month | |||||
| %Chg | +34.01% since 02/13/26 | +16.09% since 02/13/26 | -3.90% since 02/13/26 | ||
| Low | 1.96 on 03/30/26 | 1.17 on 03/20/26 | 3.41 on 04/29/26 | ||
| High | 3.65 on 04/21/26 | 2.62 on 05/14/26 | 5.15 on 03/12/26 | ||
| 6-Month | |||||
| %Chg | +41.18% since 11/14/25 | +10.99% since 11/14/25 | +14.20% since 11/14/25 | ||
| Low | 1.70 on 12/23/25 | 1.17 on 03/20/26 | 3.23 on 11/17/25 | ||
| High | 3.65 on 04/21/26 | 2.62 on 05/14/26 | 5.15 on 03/12/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 188,879 | 189,722 | 188,519 | ||
| Shares Outstanding, K | 71,545 | 93,922 | 50,951 | ||
| Annual Sales | 0 | 10,190,000 | 0 | ||
| Annual Net Income | -104,080,000 | -55,640,000 | 13,270,000 | ||
| Last Quarter Sales | 0 | N/A | 0 | ||
| Last Quarter Net Income | -27,410,000 | N/A | -16,860,000 | ||
| 60-Month Beta | 0.88 | 0.22 | 0.55 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.37 on 05/12/26 | N/A | -0.35 on 05/12/26 | ||
| Earnings Date | 08/11/26 | 05/13/26 | 08/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||